The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,936
Sort by:
Ulcerative Colitis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (Anti-Inflammatory Drugs, Anti-TNF biologics, Immuno-suppressants, Calcineurin Inhibitors, and Other), By Disease Type (Ulcerative Proctitis, Proctosigmoiditis, Left-sided Colitis, Pancolitis or Universal Colitis, and Fulminant Colitis), By Region & Competition. 2021-2031F
US$ 4,500.00
The Global Ulcerative Colitis Market will grow from USD 8.06 Billion in 2025 to USD 11.36 Billion by 2031 at a 5.89% CAGR. Ulcerative colitis is a chronic inflammatory bowel disease characterized by c...
January 2026
180 pages
Lice Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Pediculosis Capitis, Pediculosis Corporis, Pediculosis Pubis), By Drugs (OTC Drugs, Prescription Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Lice Treatment Market will grow from USD 1.14 Billion in 2025 to USD 1.57 Billion by 2031 at a 5.48% CAGR. The Global Lice Treatment Market encompasses topical pediculicides, such as shampo...
January 2026
180 pages
Global Aprotinin Supply, Demand and Key Producers, 2026-2032
US$ 4,480.00
The global Aprotinin market size is expected to reach $ 267450 million by 2032, rising at a market growth of 4.5% CAGR during the forecast period (2026-2032). Aprotinin, also known as bovine pancreati...
January 2026
129 pages
Global Atropine Supply, Demand and Key Producers, 2026-2032
US$ 4,480.00
The global Atropine market size is expected to reach $ 437 million by 2032, rising at a market growth of -1.7% CAGR during the forecast period (2026-2032). Atropine is a medication to treat certain ty...
January 2026
134 pages
Global Hirudin Supply, Demand and Key Producers, 2026-2032
US$ 4,480.00
The global Hirudin market size is expected to reach $ 5491 million by 2032, rising at a market growth of 3.0% CAGR during the forecast period (2026-2032). Hirudin is a potent anticoagulant protein ori...
January 2026
142 pages
